An Injectable HIV Treatment Developed by British Drugmaker GlaxoSmithKline is Offering ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'An injectable HIV treatment developed by British drugmaker GlaxoSmithKline is offering hope to patients in Uganda. Results of the WHO-approved trial are due in 2024 ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)